4th European Congress on Rett Syndrome: final program

Dear friends, the final program of the upcoming European Congress on Rett Syndrome can be visualized at a glance on the congress website. A full printable brochure can also be downloaded here. See you in Rome!

25 October 2015

Dear friends, the final program of the upcoming European Congress on Rett Syndrome can be visualized at a glance on the congress website.

A full printable brochure can also be downloaded here.

See you in Rome!

← Back to all news

More news

All news →

26 June 2026

A hopeful milestone for the Rett community in Europe

Rett Syndrome Europe welcomes the positive CHMP opinion for Daybu (trofinetide), a meaningful milestone for families affected by Rett syndrome across Europe.
Read →
22 June 2026

Taysha Reports Progress on TSHA-102 Gene Therapy for Rett Syndrome

Taysha Gene Therapies has shared positive longer-term interim data from its investigational gene therapy TSHA-102, with dosing now complete in the pivotal…
Read →
8 June 2026

Hopeful Progress: Gene Therapy Trial for Rett Syndrome Completes Enrollment

Neurogene has announced the successful completion of enrollment in the EMBOLDEN trial of NGN-401, an investigational gene therapy for Rett syndrome. The…
Read →

4th European Congress on Rett Syndrome: final program

More news

A hopeful milestone for the Rett community in Europe

Taysha Reports Progress on TSHA-102 Gene Therapy for Rett Syndrome

Hopeful Progress: Gene Therapy Trial for Rett Syndrome Completes Enrollment